tirzepatide phase 2 A drug called apitegromab may help to preserve lean body mass during weight loss with tirzepatide, a GLP-1 receptor agonist, according to a clinical trial published in Nature Medicine. The Read now: The SURPASS-EARLY trial

The dependent variables were selected to measure both physiological responses and subjective exertion: Heart rate: Used to assess cardiovascular function during exercise and track changes in heart rate with the different interventions

Avoid this form entirely if you are on a GLP-1 medication

The longer waste sits there, the more water gets absorbed out of it, making stools harder and more difficult to pass

Increasing water intake and eating regular small meals usually resolves them

Personalized Care at Elite Primary Care Group: At Elite Primary Care Group, we recognize that every patients response to medications like Mounjaro or Ozempic can differ